Kryger Capital’s Day One Biopharmaceuticals DAWN Stock Holding History

Kryger Capital’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,896,485	Closed	-$83.5M	–	114
2026 Q1	$83.5M	Buy	+3,896,485	New	+$54.9M	5.91%	8

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Kryger Capital's DAWN Position: Q2 2026 in Review

Kryger Capital sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 3,896,485 shares — an estimated $83.5M sold.

Kryger Capital first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $83.5M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Kryger Capital reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Kryger Capital sold 3,896,485 Day One Biopharmaceuticals shares in Q2 2026, an estimated $83.5M.
Kryger Capital first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Kryger Capital's Day One Biopharmaceuticals position peaked at $83.5M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Kryger Capital's 13F filing for Q2 2026, filed 14 Aug 2026.